Skip to main content
Top

Atypical Kawasaki disease with giant coronary artery aneurysms in a 2-month-old boy: a case report

Published in:

Abstract

Background

Kawasaki disease is an acute inflammatory disorder primarily affecting medium-sized blood vessels, especially in infants and young children under 5 years old, characterized by inflammation of the arterial walls, including coronary arteries. While predominantly affecting young children, rarely Kawasaki disease is seen in adults. Reporting this case is crucial due to the patient’s very young age and the disease’s unusual presentation following vaccination, contributing to the limited literature on Kawasaki disease in very young infants.

Case presentation

A full-term, 2-month-and-10-day-old Iranian boy presented with persistent fever unresponsive to treatment, beginning 5 days after receiving the 5-in-1 vaccine. Although physical examination results were normal, his medical history included maternal hypothyroidism during pregnancy and neonatal jaundice that did not require hospitalization. Initial laboratory tests revealed bicytopenia, thrombocytosis on the complete blood count, and elevated erythrocyte sedimentation rate and C-reactive protein levels. Echocardiography identified giant coronary artery aneurysms. The patient was diagnosed with atypical Kawasaki disease and treated with intravenous immunoglobulin, methylprednisolone, infliximab, and aspirin, which resolved his fever.

Conclusions

This case emphasizes the importance of considering Kawasaki disease as a differential diagnosis in infants with persistent, treatment-resistant fever and abnormal complete blood count findings. Early diagnosis and timely intervention are essential to prevent severe complications, such as coronary artery aneurysms and possible mortality. It underscores the need for heightened awareness and vigilance among healthcare providers in similar clinical scenarios.
Title
Atypical Kawasaki disease with giant coronary artery aneurysms in a 2-month-old boy: a case report
Authors
Najmeh Navidi
Babak Najibi
Negar Dinarvand
Amirmohammad Zamani
Mohammad Reza Fathi
Publication date
20-12-2024
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2024
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-024-04987-1
This content is only visible if you are logged in and have the appropriate permissions.

SLE: translating guidelines into practice (Link opens in a new window)

Equip yourself to confidently implement the latest evidence-based strategies for your patients with systemic lupus erythematosus with this program. Expert-led videos on topics including the updated EULAR 2023 guidelines available now.

Independent Medical Education Grant:
  • AstraZeneca
Learn more TODO (Link opens in a new window)

Keynote webinar | Spotlight on advances in lupus

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Learn more about novel biomarkers for diagnosis and monitoring, and familiarize yourself with current and emerging targeted therapies.

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Watch now
Video
Image Credits
CT angiography of 2-month-old with atypical Kawasaki disease/© 2024, Najmeh Navidi et al, J Med Case Reports, Butterfly logo superimposed over silhouettes of people/© Springer Health+ IME, Lupus concept/© (M) Vitalii But / stock.adobe.com / Generated with AI